why choose us

First received: August 09, 2023

Clinical Trial: A Study to Investigate The Safety, Tolerability, And Immune Response of a Range of Doses of mRNA-1769 Compared With Placebo in Healthy Participants From ?18 Years of Age to <50 Years of Age

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Smallpox

Study Type: INTERVENTIONAL


Official Title: A Randomised, Placebo-Controlled, Dose-Ranging, Observer-Blind Phase 1/2 Study to Evaluate the Safety, Tolerability, and Immunogenicity of mRNA-1769 in Healthy Participants

Brief Summary: The goal of this study is to assess the safety, tolerability and immunogenicity of mRNA-1769 in healthy adult participants.

Read more